Maria Sainz

CIK: 0001437768

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PLSE

PULSE BIOSCIENCES, INC.

Director

HYPR

Hyperfine, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

PLSE
PULSE BIOSCIENCES, INC.
Jun 11, 2026
Award(A)
Stock Option (right to buy)
Direct
30K shares-
PLSE
PULSE BIOSCIENCES, INC.
Jun 11, 2026
Award(A)
Stock Option (right to buy)
Direct
3.8K shares-
HYPR
Hyperfine, Inc.
Mar 31, 2026
Award(A)
Direct
750K shares-
PLSE
PULSE BIOSCIENCES, INC.
Feb 5, 2026
Award(A)
Stock Option (right to buy)
Direct
3.1K shares-
PLSE
PULSE BIOSCIENCES, INC.
Jan 8, 2026
Award(A)
Stock Option (right to buy)
Direct
50K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	PLSE PULSE BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Jun 11, 2026	PLSE PULSE BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	3,793	-	-	Direct
Mar 31, 2026	HYPR Hyperfine, Inc.	Award(A)	750,000	-	$0	Direct
Feb 5, 2026	PLSE PULSE BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	3,104	-	-	Direct
Jan 8, 2026	PLSE PULSE BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	50,000	-	-	Direct

1-5 of 5 transactions

About Sainz Maria

Sainz Maria (SEC CIK 0001437768) files insider reports with the SEC as Director of PULSE BIOSCIENCES, INC. (PLSE) and President and CEO of Hyperfine, Inc. (HYPR).

Signal8 holds 4 ownership filings by Sainz Maria (1 Form 3, 3 Form 4), filed between Feb 6, 2026 and Jun 15, 2026. Those filings report 5 transactions, from Jan 8, 2026 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sainz Maria's filings is in HAYWARD, CA.

Recent filings by Sainz Maria

Jun 11, 2026: Grants or awards of PLSE derivative securities (2 lines, Form 4, code A).
Mar 31, 2026: Grant or award of HYPR shares (Form 4, code A).
Feb 5, 2026: Grant or award of PLSE derivative securities (Form 4, code A).
Jan 8, 2026: Grant or award of PLSE derivative securities (Form 4, code A).

Other insiders filing for PULSE BIOSCIENCES, INC. (PLSE)

Teplitsky Liane Rae, Chief Operating Officer
Skinner Jon, Chief Financial Officer
Zanganeh Mahkam, Director
van den Broek Richard, Director
DUGGAN ROBERT W, Director
Soni Manmeet Singh, Director

How to read Form 4 transaction codes